DK1987817T3 - Farmaceutisk sammensætning til mikrosfærer til forebyggelse af diabetisk fodamputation - Google Patents

Farmaceutisk sammensætning til mikrosfærer til forebyggelse af diabetisk fodamputation

Info

Publication number
DK1987817T3
DK1987817T3 DK07702319T DK07702319T DK1987817T3 DK 1987817 T3 DK1987817 T3 DK 1987817T3 DK 07702319 T DK07702319 T DK 07702319T DK 07702319 T DK07702319 T DK 07702319T DK 1987817 T3 DK1987817 T3 DK 1987817T3
Authority
DK
Denmark
Prior art keywords
microspheres
prevention
pharmaceutical composition
diabetic foot
foot amputation
Prior art date
Application number
DK07702319T
Other languages
English (en)
Inventor
Martinez Vivian Maria Saez
Meireles Rolando Paez
Acosta Jorge Amador Berlanga
Hernandez Jose Angel Ram0N
Rodriguez Blas Yamir Betancourt
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38185604&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1987817(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of DK1987817T3 publication Critical patent/DK1987817T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK07702319T 2006-01-31 2007-01-29 Farmaceutisk sammensætning til mikrosfærer til forebyggelse af diabetisk fodamputation DK1987817T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20060021A CU23388B6 (es) 2006-01-31 2006-01-31 Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
PCT/CU2007/000002 WO2007087759A2 (es) 2006-01-31 2007-01-29 Composición farmacéutica de microesferas para prevenir la amputación del pie diabético

Publications (1)

Publication Number Publication Date
DK1987817T3 true DK1987817T3 (da) 2009-11-30

Family

ID=38185604

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07702319T DK1987817T3 (da) 2006-01-31 2007-01-29 Farmaceutisk sammensætning til mikrosfærer til forebyggelse af diabetisk fodamputation

Country Status (24)

Country Link
US (1) US8741848B2 (da)
EP (1) EP1987817B1 (da)
JP (1) JP5219841B2 (da)
KR (1) KR101401273B1 (da)
CN (2) CN103933552A (da)
AR (1) AR059234A1 (da)
AT (1) ATE437631T1 (da)
AU (1) AU2007211753B2 (da)
BR (1) BRPI0707395A2 (da)
CA (1) CA2640743C (da)
CU (1) CU23388B6 (da)
CY (1) CY1109513T1 (da)
DE (1) DE602007001786D1 (da)
DK (1) DK1987817T3 (da)
ES (1) ES2330688T3 (da)
HK (1) HK1198743A1 (da)
MY (1) MY143742A (da)
PL (1) PL1987817T3 (da)
PT (1) PT1987817E (da)
RU (1) RU2426528C2 (da)
SG (1) SG169366A1 (da)
SI (1) SI1987817T1 (da)
WO (1) WO2007087759A2 (da)
ZA (1) ZA200806648B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23411B6 (es) * 2005-12-29 2009-09-08 Ct Ingenieria Genetica Biotech Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético
ES2340902B1 (es) 2008-07-01 2011-05-03 Laboratorios Farmaceuticos Rovi, S.A. Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
KR101156094B1 (ko) * 2010-02-22 2012-06-20 경상대학교산학협력단 약물송달을 위한 양친성 ＰＨＡ－ｍＰＥＧ 공중합 나노 컨테이너
ES2357601B1 (es) 2011-01-26 2012-03-21 Laboratorios Farmacéuticos Rovi, S.A. Procedimiento de preparación de derivados de glicosaminoglicanos donadores de óxido n�?trico y su uso en tratamiento de úlceras crónicas.
EP2737895A1 (en) * 2012-11-30 2014-06-04 Praxis Pharmaceutical, S.A. Microparticles with EGF, method of preparation and use
EP2821077A1 (en) 2013-07-04 2015-01-07 Praxis Biopharma Research Institute Lipid nanoparticles for wound healing
EP3097922A1 (fr) 2015-05-28 2016-11-30 Denis Barritault Composition pour le traitement des lesions tissulaires
CN106267163A (zh) * 2015-06-09 2017-01-04 济南博创医药科技有限公司 一种治疗皮肤创伤的药物组合物及其药物制剂
MX2016016339A (es) * 2016-12-09 2018-06-08 Desarrolladora Y Com De Tecnologias Biomedicas Decotecbio S A S De C V Composicion coadyuvante de un factor de crecimiento y un neuropeptido para acelerar la cicatrizacion de heridas y la repitelizacion de organos.
KR102218427B1 (ko) * 2017-09-20 2021-02-22 차의과학대학교 산학협력단 단백질 약물을 포함하는 코아세르베이트 조성물 및 이를 포함하는 창상 치료제
CU20190022A7 (es) * 2019-03-18 2020-10-20 Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma Composición farmacéutica para el tratamiento de la úlcera del pie diabético

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
NZ226171A (en) 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
JP2670680B2 (ja) * 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
US5034375A (en) 1988-08-10 1991-07-23 Institute Of Molecular Biology, Inc. Process of wound healing using PDGF and EGF
US4944948A (en) 1989-02-24 1990-07-31 Liposome Technology, Inc. EGF/Liposome gel composition and method
KR920700691A (ko) 1989-04-04 1992-08-10 존.에프.맥인티리 상처부위, 절개부위, 찰과상 부위에 치료제의 투여에 대한 리포좀(liposomes)의 용도
US5130298A (en) 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
WO1991001719A1 (en) 1989-08-01 1991-02-21 The University Of Michigan Topical delivery of peptides/proteins entrapped in dehydration/rehydration liposomes
AU629316B2 (en) 1990-04-11 1992-10-01 Flora Inc. Periodontal disease treatment system
US6902743B1 (en) * 1995-05-22 2005-06-07 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
CA2251129A1 (en) * 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
US5861149A (en) * 1997-06-04 1999-01-19 Polyheal Ltd. Methods for wound treatment
EP1353701B1 (en) * 2000-10-31 2011-12-21 PR Pharmaceuticals, Inc. Methods for producing compositions for enhanced delivery of bioactive molecules
HK1077740A1 (en) * 2001-12-20 2006-02-24 Ct Ingenieria Genetica Biotech Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation
TWI348912B (en) 2002-03-12 2011-09-21 Method and composition for treating skin wounds with epidermal growth factor
CN1720989A (zh) 2004-07-15 2006-01-18 深圳市清华源兴生物医药科技有限公司 一种表皮生长因子缓释微球及其制备方法与应用
CU23411B6 (es) 2005-12-29 2009-09-08 Ct Ingenieria Genetica Biotech Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético

Also Published As

Publication number Publication date
ES2330688T3 (es) 2009-12-14
CN103933552A (zh) 2014-07-23
AU2007211753B2 (en) 2012-03-01
EP1987817A2 (en) 2008-11-05
JP5219841B2 (ja) 2013-06-26
JP2009525288A (ja) 2009-07-09
SG169366A1 (en) 2011-03-30
EP1987817B1 (en) 2009-07-29
SI1987817T1 (sl) 2009-12-31
DE602007001786D1 (de) 2009-09-10
PT1987817E (pt) 2009-10-26
KR101401273B1 (ko) 2014-05-29
CN101400338A (zh) 2009-04-01
RU2426528C2 (ru) 2011-08-20
US8741848B2 (en) 2014-06-03
US20090220608A1 (en) 2009-09-03
WO2007087759A2 (es) 2007-08-09
AR059234A1 (es) 2008-03-19
BRPI0707395A2 (pt) 2011-05-03
CA2640743A1 (en) 2007-08-09
CU23388B6 (es) 2009-07-16
PL1987817T3 (pl) 2010-01-29
RU2008135354A (ru) 2010-03-10
CY1109513T1 (el) 2014-08-13
MY143742A (en) 2011-07-15
WO2007087759A3 (es) 2007-09-20
HK1198743A1 (en) 2015-06-05
ZA200806648B (en) 2009-05-27
ATE437631T1 (de) 2009-08-15
AU2007211753A1 (en) 2007-08-09
KR20080096804A (ko) 2008-11-03
CA2640743C (en) 2012-05-15

Similar Documents

Publication Publication Date Title
DK1987817T3 (da) Farmaceutisk sammensætning til mikrosfærer til forebyggelse af diabetisk fodamputation
LTPA2018005I1 (lt) Farmacinė kompozicija
DK2054073T3 (da) Farmaceutiske præparater til fremføring med langvarig frigivelse af peptider
DK2345410T3 (da) Farmaceutisk sammensætning til modificeret frigivelse
DK2046264T3 (da) Fremgangsmåder til fremstillingen af sammensætninger med film
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
BRPI0715712A2 (pt) Composição farmacêutica
BRPI0719393A2 (pt) Composição farmacêutica
ES2527409T4 (es) Formulaciones de inhibidores de DPP IV
DK2046767T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK2014652T3 (da) Aktiveringsmiddel til peroxisom-proliferator-aktiveret receptor
DK2114386T3 (da) Farmaceutisk sammensætning til behandling af diabeteskomplikationer
BRPI0721651A2 (pt) Composição farmacêutica
DK1984009T3 (da) Farmaceutiske sammensætninger med forbedret stabilitet
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2063868T3 (da) Farmaceutiske sammensætninger indeholdende rosuvastatin-calcium
DK2478907T3 (da) Sammensætninger til behandling af kræft
DK2011486T3 (da) Farmaceutiske sammensætninger af rifaximin
DK2180882T3 (da) Farmaceutisk faststofsammensætning af matrix-type
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0720234A2 (pt) Composição farmacêutica
DK2079577T3 (da) Fremgangsmåde til fremstilling af fodtøj
DK2120884T3 (da) Farmaceutisk sammensætning
NO20091266L (no) Fremgangsmåter for administrering av langvarige hypoglykemiske midler
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme